INDOCONSEIndoco Remedies Limited· PharmaceuticalsMediumNeutral
Announced Thu, 18 Dec · 12:37 IST

Aditi Milind Panandikar has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Aditi Milind Panandikar, a member of the promoter group of Indoco Remedies, has filed a disclosure under Regulation 10(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires disclosure of inter se transfers of shares between promoters or within the promoter group. No details on the size, direction, or counterparty of the transfer have been provided in the headline. The overall promoter group shareholding in the company is not expected to change materially from such an internal transfer.

Likely market impact

This is largely an internal promoter-group restructuring disclosure and typically has a neutral impact on the stock price and on total promoter holding in the company.